Stryker (NYSE:SYK) is taking its time getting the Mako robot-assisted Triathlon total knee device on the market, despite having won FDA approval last August. Admitting that the integration of Mako after the $1.7 billion acquisition in December 2013 was “messy,” CEO Kevin Lobo said Stryker isn’t planning to launch the total knee offering until 2017. […]
FDA clears Stryker’s total knee for Mako robot-assisted surgery device
Stryker (NYSE:SYK) said yesterday that it won 510(k) clearance from the FDA for a total knee tool for the Mako Surgical robot-assisted surgery platform it bought in 2013. Stryker now has Mako-compatible offerings for total and partial knee replacement and total hip replacement, the company said. “The ability to include a Mako total knee application with our market leading […]
Mako’s Q4 turnaround has Stryker feeling confident
JNJ/Synthes integration continues to bring hefty charges | The week in medtech M&A
Stryker: Mako sales not as strong as we hoped
Medtech M&A analysis: 41 device companies sold in 2013
Total deal volume in the medical device industry contracted by about 13% in 2013, according to new analysis from audit shop PricewaterhouseCoopers.
Stryker closes $1.7B buyout of Mako Surgical
Mako Surgical’s shareholders OK $1.7B Stryker buyout
Mako Surgical settles shareholders’ lawsuits ahead of Stryker buyout
Mako management discuss Q2 earnings
Mako’s Q3 numbers drop, outlook clears in the midst of Stryker merger
- 1
- 2
- 3
- …
- 6
- Next Page »
